Suez Canal University is hosting a focused clinical evaluation on the wear resistance and bioactivity of new self-cured bioactive resin composites. Designed for dental professionals, researchers, and regulatory teams, this study advances our understanding of innovative materials for treating Class II dental caries.
In This Article
What is the focus of the study?
The clinical trial explores the wear resistance and ability to promote biomineralization of two resin composite materials—nanohybrid composites and bioactive resin composites—for treating dental caries, specifically Class II cases. The findings could have implications for better patient outcomes by using materials that resist wear and contribute to dental tissue regeneration.
Dental caries, a major oral health issue, requires reliable materials to ensure long-lasting restorations. Bioactive resin composites promise benefits such as calcium and phosphate ion release to enhance remineralization, offering a dual-functionality beyond traditional restorations.
What procedures are being investigated?
The study includes two intervention arms:
- Nanohybrid Resin Composites: These materials are known for their superior aesthetic properties and polishability, making them ideal for visible restorations.
- Bioactive Resin Composites: Designed with bioactive fillers, these materials aim to support remineralization processes alongside restorative functionality.
The testing includes clinical wear assessments and bioactivity evaluations. Experts are extending their analysis over multiple patients invited to enroll based on specific inclusion criteria.
Who does this impact?
Dental manufacturers, quality assurance teams, and regulatory professionals should pay close attention to this trial. Material performance data could influence how resin composites are regulated and adopted for clinical use globally.
Additionally, practitioners and oral health researchers may benefit from the trial’s insights to make evidence-based decisions regarding restorative materials for Class II caries treatments. Institutions looking for collaborative opportunities in the development of bioactive materials might also find value here.
FAQ
- What are the expected outcomes of the trial?
The trial aims to measure the wear resistance and bioactivity of resin composites for better clinical durability and potential remineralization effects. - When is the study being conducted?
The enrollment is by invitation, with updates occurring regularly, based on the trial record. - Will the results impact medical device regulations?
The findings will likely inform material certifications and product development compliance, especially for bioactive dental materials.
Conclusion
This clinical trial from Suez Canal University represents a step forward in dental material science. By assessing wear resistance and bioactivity, the study aims to empower medical device manufacturers and healthcare providers with robust data to enhance restorative practices.
Stay tuned for detailed outcome updates to understand their impact on the future of bioactive resin regulations.
Disclaimer
This blog post is for informational purposes only. It does not constitute legal or regulatory advice. For specific guidance, consult appropriate regulatory authorities or professionals.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07262086?term=medical+device